Olfr627, a prominent member of the olfactory receptor protein family, plays a pivotal role in orchestrating the intricate process of olfaction. This G-protein-coupled receptor (GPCR) is intricately involved in the recognition and transduction of odorant signals within the olfactory system. The olfactory receptors, including Olfr627, are characterized by a 7-transmembrane domain structure, reminiscent of other GPCRs involved in neurotransmission and hormone signaling. These receptors arise from single coding-exon genes, contributing to the immense diversity within the olfactory receptor gene family. Functionally, Olfr627 is tasked with initiating a neuronal response upon interaction with odorant molecules. This interaction triggers a cascade of events, leading to the perception of smell. The GPCR-mediated transduction of odorant signals is a finely tuned process that involves intricate cellular and biochemical pathways. The olfactory receptor gene family stands as the largest in the genome, highlighting its significance in enabling organisms to discriminate and respond to a vast array of olfactory stimuli. The nomenclature assigned to olfactory receptor genes and proteins is organism-specific, emphasizing the unique and independent nature of these receptors across different species.
Inhibition of Olfr627 involves a sophisticated interplay between various chemical compounds and cellular processes. These inhibitors act either directly by binding to the receptor site and disrupting the interaction with odorant molecules or indirectly by modulating specific signaling pathways associated with Olfr627. The direct inhibitors interfere with the receptor's ability to recognize and transduce olfactory signals, thereby impeding the initiation of the neuronal response responsible for the perception of smell. On the other hand, indirect inhibitors influence various intracellular cascades, disrupting downstream events associated with Olfr627 function. This intricate network of inhibition sheds light on the complex molecular mechanisms governing olfaction, contributing to our understanding of sensory processes at the molecular level. The study of Olfr627 and its inhibition provides valuable insights into the regulation of olfactory receptor function and the potential modulation of odor perception.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin inhibits the PI3K/Akt pathway, which may indirectly affect Olfr627 through downstream signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits PI3K, potentially impacting Olfr627 by modulating the PI3K/Akt pathway and downstream signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that could indirectly influence Olfr627 by modulating the p38 MAPK pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is a MEK inhibitor that may indirectly suppress Olfr627 by inhibiting the MAPK pathway and downstream signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, potentially affecting Olfr627 expression through its regulation of the mTOR pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that might indirectly influence Olfr627 through the JNK pathway and its downstream effects. | ||||||